Amarin Announces Publication of REDUCE-IT Cardiovascular Outcomes Study Rationale and Design in Clinical Cardiology Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Announces Publication of REDUCE-IT Cardiovascular Outcomes Study Rationale and Design in Clinical Cardiology
Amarin Reports Second Quarter 2016 Financial Results and Provides Update on Operations Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Reports Second Quarter 2016 Financial Results and Provides Update on Operations
Amarin Announces Proposed Public Offering of American Depositary Shares Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Announces Proposed Public Offering of American Depositary Shares
Amarin Prices Public Offering of American Depositary Shares Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Prices Public Offering of American Depositary Shares
Amarin Announces Underwriters' Exercise of Option to Purchase Additional American Depositary Shares Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Announces Underwriters' Exercise of Option to Purchase Additional American Depositary Shares
Amarin Announces Mandatory Exchange of Exchangeable Senior Notes Issued in May 2014 and November 2015 Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Announces Mandatory Exchange of Exchangeable Senior Notes Issued in May 2014 and November 2015
Amarin Randomizes Final Patient into REDUCE-IT Cardiovascular Outcomes Study of Vascepa Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Randomizes Final Patient into REDUCE-IT Cardiovascular Outcomes Study of Vascepa
Amarin to Present at the Rodman & Renshaw 18th Annual Global Investment Conference Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin to Present at the Rodman & Renshaw 18th Annual Global Investment Conference
Amarin's REDUCE-IT Cardiovascular Outcomes Study of Vascepa to Continue as Planned at Recommendation of Independent Data Monitoring Committee Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin's REDUCE-IT Cardiovascular Outcomes Study of Vascepa to Continue as Planned at Recommendation of Independent Data Monitoring Committee
Pure EPA Vascepa® Now Available in New, Smaller Half-Gram Capsule Size Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Pure EPA Vascepa® Now Available in New, Smaller Half-Gram Capsule Size
